Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma…
June 06, 2025 16:01 ET Â | Source: Replimune Group Inc WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group,…